Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jeffrey G. Kuremsky"'
Autor:
Kevin S. Roof, MD, Jerome M. Butler, Jr., MD, Vipul V. Thakkar, MD, Robert M. Doline, MD, Jeffrey G. Kuremsky, MD, John B. Konefal, MD, Robert J. McCammon, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 1, Pp 100579- (2021)
Purpose: This study aimed to report our initial experience with weekly tele-video “virtual” on-treatment visits (vOTVs), describe the logistics of implementation, report the results of patient and physician surveys, and discuss the barriers, limi
Externí odkaz:
https://doaj.org/article/8a4d2d80b2814bd8baa748bd4fc9f0e3
Autor:
Vipul V. Thakkar, Jeffrey G. Kuremsky, Robert J. McCammon, Robert M. Doline, John B. Konefal, Jerome M. Butler, Kevin S. Roof
Publikováno v:
Advances in Radiation Oncology
Advances in Radiation Oncology, Vol 6, Iss 1, Pp 100579-(2021)
Advances in Radiation Oncology, Vol 6, Iss 1, Pp 100579-(2021)
Purpose This study aimed to report our initial experience with weekly tele-video “virtual” on-treatment visits (vOTVs), describe the logistics of implementation, report the results of patient and physician surveys, and discuss the barriers, limit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a581b143480842fc035f30f9d5647e44
https://pubmed.ncbi.nlm.nih.gov/33083637
https://pubmed.ncbi.nlm.nih.gov/33083637
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 74:673-688
Locally advanced rectal cancer (LARC) is currently treated with neoadjuvant chemoradiation. Although approximately 45% of patients respond to neoadjuvant therapy with T-level downstaging, there is no effective method of predicting which patients will
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f58428fa5066a4f485251ac38fe330b
https://doi.org/10.1016/j.ijrobp.2009.03.003
https://doi.org/10.1016/j.ijrobp.2009.03.003
Autor:
Nidhi Bansal, Jade Mims, Jeffrey G. Kuremsky, Amy L. Olex, Weiling Zhao, Leimiao Yin, Revati Wani, Jiang Qian, Brian Center, Glen S. Marrs, Mercedes Porosnicu, Jacquelyn S. Fetrow, Allen W. Tsang, Cristina M. Furdui
Publikováno v:
Antioxidantsredox signaling. 21(2)
Aims: The central issue of resistance to radiation remains a significant challenge in the treatment of cancer despite improvements in treatment modality and emergence of new therapies. To facilitate the identification of molecular factors that elicit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0c079ec8c63f507a2098d4d35fad91b
https://pubmed.ncbi.nlm.nih.gov/24597745
https://pubmed.ncbi.nlm.nih.gov/24597745
Autor:
Thomas H. Bugge, Alfredo A. Molinolo, Stephen H. Leppla, Marissa Kuhnen, Shihui Liu, Jeffrey G. Kuremsky, Vivien Redeye
Publikováno v:
Nature biotechnology. 23(6)
Anthrax toxin protective antigen (PrAg) forms a heptamer in which the binding site for lethal factor (LF) spans two adjacent monomers. This suggested that high cell-type specificity in tumor targeting could be obtained using monomers that generate fu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::042b1dbf56e306ccd42d3aa429502f7d
https://pubmed.ncbi.nlm.nih.gov/15895075
https://pubmed.ncbi.nlm.nih.gov/15895075
Diphthamide, a posttranslational modification of translation elongation factor 2 that is conserved in all eukaryotes and archaebacteria and is the target of diphtheria toxin, is formed in yeast by the actions of five proteins, Dph1 to -5, and a still
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e90f5b69218a1e04208660aef9e890b7
https://europepmc.org/articles/PMC522255/
https://europepmc.org/articles/PMC522255/
